Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
    Users Online: 169
Home Print this page Email this page Small font size Default font size Increase font size
Year : 2020  |  Volume : 9  |  Issue : 2  |  Page : 160-163

Intestinal strongyloidiasis in a patient of myasthenia gravis and diabetes mellitus

Department of Microbiology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India

Correspondence Address:
Prachala Rathod
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/sjhs.sjhs_225_19

Rights and Permissions

Strongyloidiasis is endemic in tropical and subtropical countries. It can become fatal and life-threatening in immunocompromised patients. We report a case of a 36-year-old female who was diagnosed with myasthenia gravis and type II diabetes mellitus. The patient complained of diarrhea with fever, vomiting, and dyspnea. On examination of stool in wet mount, 10–15 motile larvae/high-power field were seen. A methylene blue staining of fecal specimen was done to confirm the larvae as rhabditiform larvae of Strongyloides stercoralis. The patient was successfully treated with ivermectin. The authors recommend that in patients with myasthenia gravis, presenting with gastrointestinal manifestations, strongyloidiasis should be suspected, investigated, and treated accordingly.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded31    
    Comments [Add]    

Recommend this journal